| Clinical implications of 20-hydroxyeicosatetraenoic acid in the kidney, liver, lung and brain: an emerging therapeutic target OH Elshenawy, SM Shoieb, A Mohamed, AOS El-Kadi Pharmaceutics 9 (1), 9, 2017 | 55 | 2017 |
| Chrysin attenuates testosterone-induced benign prostate hyperplasia in rats SM Shoieb, A Esmat, AE Khalifa, AB Abdel-Naim Food and Chemical Toxicology 111, 650-659, 2018 | 50 | 2018 |
| Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms MA El-Ghiaty, SM Shoieb, AOS El-Kadi Medical hypotheses 144, 110033, 2020 | 46 | 2020 |
| Metformin attenuates testosterone-induced prostatic hyperplasia in rats: a pharmacological perspective HH Mosli, A Esmat, RT Atawia, SM Shoieb, HA Mosli, AB Abdel-Naim Scientific reports 5 (1), 15639, 2015 | 45 | 2015 |
| Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites N Matsumura, S Takahara, ZH Maayah, N Parajuli, NJ Byrne, SM Shoieb, ... Journal of molecular and cellular cardiology 125, 162-173, 2018 | 38 | 2018 |
| Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states SM Shoieb, AA El-Sherbeni, AOS El-Kadi Chemico-biological interactions 299, 140-150, 2019 | 33 | 2019 |
| S-enantiomer of 19-hydroxyeicosatetraenoic acid preferentially protects against angiotensin II-induced cardiac hypertrophy SM Shoieb, AOS El-Kadi Drug Metabolism and Disposition 46 (8), 1157-1168, 2018 | 33 | 2018 |
| Cytochrome P450-derived eicosanoids and inflammation in liver diseases SM Shoieb, MA El-Ghiaty, MA Alqahtani, AOS El-Kadi Prostaglandins & other lipid mediators 147, 106400, 2020 | 29 | 2020 |
| Targeting arachidonic acid–related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles SM Shoieb, MA El-Ghiaty, AOS El-Kadi Emergent materials 4 (1), 265-277, 2021 | 23 | 2021 |
| Inhibition of mid-chain HETEs protects against angiotensin II–induced cardiac hypertrophy S Elkhatali, ZH Maayah, AA El-Sherbeni, OH Elshenawy, G Abdelhamid, ... Journal of Cardiovascular Pharmacology 70 (1), 16-24, 2017 | 19 | 2017 |
| Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites SM Shoieb, AOS El-Kadi Molecular and cellular biochemistry 471 (1), 165-176, 2020 | 18 | 2020 |
| Fluconazole represses cytochrome P450 1B1 and its associated arachidonic acid metabolites in the heart and protects against angiotensin II-induced cardiac hypertrophy AH Alammari, SM Shoieb, ZH Maayah, AOS El-Kadi Journal of Pharmaceutical Sciences 109 (7), 2321-2335, 2020 | 13 | 2020 |
| Identification of 19-(S/R) hydroxyeicosatetraenoic acid as the first endogenous noncompetitive inhibitor of cytochrome P450 1B1 with enantioselective activity SM Shoieb, AA El-Sherbeni, AOS El-Kadi Drug Metabolism and Disposition 47 (2), 67-70, 2019 | 12 | 2019 |
| Ameliorative role of fluconazole against abdominal aortic constriction–induced cardiac hypertrophy in rats SM Shoieb, AH Alammari, J Levasseur, H Silver, JRB Dyck, AOS El-Kadi Journal of Cardiovascular Pharmacology 79 (6), 833-845, 2022 | 5 | 2022 |
| Novel synthetic analogues of 19 (S/R)-hydroxyeicosatetraenoic acid exhibit noncompetitive inhibitory effect on the activity of cytochrome P450 1A1 and 1B1 SM Shoieb, R Dakarapu, JR Falck, AOS El-Kadi European Journal of Drug Metabolism and Pharmacokinetics 46 (5), 613-624, 2021 | 5 | 2021 |
| 16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism R Hidayat, SM Shoieb, FES Mosa, K Barakat, DR Brocks, FA Isse, ... Molecular and Cellular Biochemistry, 1-12, 2023 | 1 | 2023 |
| The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells R Hidayat, MA El-Ghiaty, SM Shoieb, MA Alqahtani, AOS El-Kadi European Journal of Drug Metabolism and Pharmacokinetics 48 (6), 709-722, 2023 | | 2023 |
| Fluconazole Protects against Abdominal Aortic Constriction‐Induced Cardiac Hypertrophy SM Shoieb, J Levasseur, H Silver, JRB Dyck, AOS El‐Kadi The FASEB Journal 35, 2021 | | 2021 |
| The Role of Subterminal Hydroxyeicosatetraenoic Acids in the Pathogenesis of Cardiac Hypertrophy SMAM Shoieb | | 2021 |
| 19‐(S/R) Hydroxyeicosatetraenoic Acid is a Novel Endogenous Inhibitor of Cytochrome P450 1B1 in Enantioselective Manner S Shoieb, AA El-Sherbeni, AOS El-Kadi The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
